Otros idiomas CNBX Pharmaceuticals Inc.

Acciones

CNBX

US13764M2098

Mercado cerrado - OTC Markets Otros sitios de cotización 19:43:40 07/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,0104 ^USD	+1,47 %		-29,25 %	-26,76 %

16/04	CNBX Pharmaceuticals Inc. informa de los resultados del segundo trimestre y de los seis meses finalizados el 29 de febrero de 2024	CI
12/01	CNBX Pharmaceuticals Inc. Resultados del primer trimestre finalizado el 30 de noviembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	16/04
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	12/01
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	30/11
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	14/07/23
BigTime Penny Stocks: Unusual "Chatter" Watchlist (GEGI, AAPJ, CNBX, GTVH)	05/06/23
BigTime Penny Stocks: Potential Breakout Stocks - Watchlist (GNPX, CLNV, CNBX, WOEN)	02/06/23
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	14/04/23
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	14/04/23
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	08/02/23
CNBX Pharmaceuticals Inc. Announces Board Resignations	08/02/23
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	13/01/23
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	13/01/23
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	29/12/22
Shaul Yemal Resigns Position as Director and Board Member Cnbx Pharmaceuticals Inc	29/12/22
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	30/11/22
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	30/11/22
CNBX Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	30/11/22
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma	08/11/22
CNBX Pharmaceuticals Inc. acquired unknown stake in TaGeza Biopharmaceuticals Ltd.	08/11/22
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy	18/10/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas CNBX Pharmaceuticals Inc.

Acciones

CNBX

US13764M2098

Otros idiomas

Filtros